Swiss National Bank
APLT

Swiss National Bank’s Applied Therapeutics APLT Stock Holding History

Swiss National Bank’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-146,900
Closed -$126K – 2401
2024
Q4 		$126K Buy
+146,900
New +$921K ﹤0.01% 2439
2022
Q2 		– Sell
-37,300
Closed -$79K – 2745
2022
Q1 		$79K Hold
37,300
– – ﹤0.01% 2690
2021
Q4 		$334K Hold
37,300
– – ﹤0.01% 2711
2021
Q3 		$619K Hold
37,300
– – ﹤0.01% 2554
2021
Q2 		$775K Buy
37,300
+2,700
+8% +$51.1K ﹤0.01% 2553
2021
Q1 		$649K Buy
34,600
+4,200
+14% +$90.6K ﹤0.01% 2430
2020
Q4 		$669K Buy
30,400
+1,000
+3% +$20.8K ﹤0.01% 2419
2020
Q3 		$610K Hold
29,400
– – ﹤0.01% 2313
2020
Q2 		$1.06M Buy
+29,400
New +$1.23M ﹤0.01% 2064

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swiss National Bank's APLT Position: Q1 2025 in Review

Swiss National Bank sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 146,900 shares — an estimated $126K sold.

Swiss National Bank first reported a position in APLT in Q2 2020 and held it in 9 quarters. The position peaked at $1.06M in Q2 2020. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • Swiss National Bank reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Swiss National Bank sold 146,900 Applied Therapeutics shares in Q1 2025, an estimated $126K.
  • Swiss National Bank first reported a position in Applied Therapeutics in Q2 2020 and held it in 9 quarters.
  • Swiss National Bank's Applied Therapeutics position peaked at $1.06M in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Swiss National Bank's 13F filing for Q1 2025, filed 12 May 2025.